Client R&D Spending Volatility: CRL's revenue depends on the research and development budgets of its biopharma clients. Economic downturns or shifts in client priorities could reduce demand for CRL's essential services.

Regulatory Scrutiny and Compliance Costs: Operating under stringent regulations (e.g., FDA, EMA, USDA) for laboratory practices, data integrity, and animal welfare exposes CRL to significant compliance costs and the risk of penalties or operational disruption from non-adherence.

Intense Competition and Pricing Pressure: The contract research organization market is highly competitive, featuring large global players and specialized firms. This environment can lead to pricing pressure, impacting CRL's profit margins and ability to maintain market share.